• Home
  • Search
  • Hormonal Contraceptives and Depression: A Proteomic Analysis Using Neuronal Models
  • https://doi.org/10.1002/prca.70017Copy DOI Icon

Hormonal Contraceptives and Depression: A Proteomic Analysis Using Neuronal Models

Show More
  • Abstract
  • Literature Map
  • References
  • Similar Papers
Abstract

ABSTRACTPurposeHormonal contraceptives are linked to a higher prevalence of depressive symptoms. Given their popularity in Western countries, understanding the biochemical effects on neuronal cells is crucial to minimizing mental health risks.Experimental DesignNeural progenitor cells were treated with ethinyl estradiol (EE) and levonorgestrel (LNG), two synthetic sex hormones commonly used in oral contraception, and S‐23, a selective androgen receptor modulator developed as a potential synthetic sex hormone for male hormonal contraception. Label‐based quantitative proteomics with the TMTpro 16plex tandem mass tags were used to assess protein expression changes between treated and untreated cells.ResultsTreatment of human neural progenitor cells with EE, LNG, EE + LNG, and S‐23 led to distinct and overlapping proteomic changes, with enrichment in pathways related to inflammation, oxidative stress, transcriptional regulation, and cell death. Disease association analyses linked these changes to neurodegenerative and psychiatric conditions, including mechanisms relevant to depression.Conclusions and Clinical RelevanceThese findings suggest that hormonal compounds used in contraception and performance enhancement may influence molecular pathways implicated in mental health, particularly depression. Although not directly translatable to clinical outcomes, the results support the need for further investigation into the neuropsychiatric effects of hormonal treatments.SummaryThis study addresses a pressing clinical need to better understand the potential mental health impacts of widely used hormonal contraceptives. While highly effective for pregnancy prevention, compounds such as ethinyl estradiol and levonorgestrel have repeatedly been associated with increased risk of depressive symptoms, highlighting the importance of investigating their molecular effects on neural systems.To explore this, we applied label‐based quantitative proteomics in an undifferentiated human neural progenitor cell model treated with ethinyl estradiol, levonorgestrel, their combination, and the selective androgen receptor modulator S‐23. The treatments induced distinct and overlapping changes in protein expression, with enrichment in pathways related to inflammation, oxidative stress, cell adhesion, chromatin dynamics, and programmed cell death—biological processes known to intersect with mechanisms implicated in depression.These findings offer insight into how synthetic hormones and hormone‐like compounds may modulate neuronal biology, potentially contributing to adverse mental health outcomes. However, due to limitations of the in vitro model—such as the absence of systemic context, pharmacokinetics, and mature neuronal function—these results are primarily hypothesis‐generating. They underscore the importance of further research to clarify the pathophysiological mechanisms linking hormonal treatments to affective disorders and to better assess the mental health risks of these compounds.

Similar Papers
  • Research Article

Synthetic estrogen and progestin effects on the myogenic program following damage in C2C12 murine myoblasts.

  • Apr 01, 2026
  • Physiological reports
  • Mai Wageh +2
  • Research Article
  • Citations4

Behavioral characterization of co-exposure to cannabinoids and hormonal contraceptives in female rats

  • Nov 03, 2023
  • Progress in Neuro-Psychopharmacology and Biological Psychiatry
  • Liana Fattore +8
  • Abstract

Comparison of ethinylestradiol pharmacokinetics in three hormonal contraceptive formulations: the vaginal ring, the transdermal patch and an oral contraceptive

  • Aug 13, 2005
  • Contraception
  • M Kaptein +3
  • Research Article

Hormone replacement Up-to-date. Selective androgen receptor modulators (SARMs). Current status and their future

  • Sep 01, 2007
  • Clinical calcium
  • Taiji Tsukamoto +2
  • Research Article
  • Citations50

Desogestrel- and levonorgestrel-containing oral contraceptives have different effects on urinary excretion of prostacyclin metabolites and serum high density lipoproteins.

  • Dec 01, 1987
  • The Journal of Clinical Endocrinology & Metabolism
  • O Ylikorkala +3
  • Research Article
  • Citations6

Automated stability-indicating high-performance liquid chromatographic assay for ethinyl estradiol and (levo)norgestrel tablets.

  • Feb 01, 1987
  • Pharmaceutical Research
  • Van D Reif +3
  • Research Article
  • Citations1

Pharmacokinetics of Oral Combination Contraceptive Drugs Containing Ethinyl Estradiol and Levonorgestrel in Healthy Female Chinese Volunteers.

  • Jun 02, 2015
  • Drug research
  • X Xin +5
  • Research Article

Mouse Model for Combined Oral Contraceptive Administration in Diet

  • Sep 03, 2025
  • Journal of Women's Sports Medicine
  • Olivia Rau +6
  • Research Article
  • Citations31

Ethinyl estradiol and levonorgestrel pharmacokinetics with a low-dose transdermal contraceptive delivery system, AG200-15: a randomized controlled trial

  • Nov 30, 2011
  • Contraception
  • David F Archer +3
  • Research Article
  • Citations9

Synthetic contraceptive hormones occlude the ability of nicotine to reduce ethanol consumption in ovary-intact female rats

  • Sep 27, 2023
  • Drug and alcohol dependence
  • Erin E Maher +15
  • Front Matter
  • Citations45

Canadian Contraception Consensus (Part 2 of 4).

  • Nov 01, 2015
  • Journal of Obstetrics and Gynaecology Canada
  • Amanda Black +19
  • Research Article
  • Citations6

Papillary Thyroid Cancer-Promoting Activities of Combined Oral Contraceptive Components.

  • May 21, 2020
  • Galen Medical Journal
  • Mehdi Hedayati +2
  • Research Article

Comparing the Cardiovascular Risk of Norethindrone Acetate & Levonorgestrel Pills: Is There a Difference? [10I

  • Apr 25, 2020
  • Obstetrics & Gynecology
  • Clare Barnett +4
  • Research Article
  • Citations11

Mental health and quality of life across 6 years of medical training: A year-by-year analysis.

  • Oct 15, 2023
  • International Journal of Social Psychiatry
  • Natalia De Castro Pecci Maddalena +4
  • PDF
  • Research Article
  • Citations21

Ethinylestradiol and Levonorgestrel as Active Agents in Normal Skin, and Pathological Conditions Induced by UVB Exposure: In Vitro and In Ovo Assessments

  • Nov 14, 2018
  • International Journal of Molecular Sciences
  • Dorina Coricovac +12
Cactus Communications logo

Copyright 2026 Cactus Communications. All rights reserved.